Anthem Blue Cross and Blue Shield Virginia policy
MED.00140 Gene Therapy for Beta Thalassemia
MED.00140 Gene Therapy for Beta Thalassemia is a public Anthem Blue Cross and Blue Shield Virginia policy (policy MED.00140). It lists 5 CPT or HCPCS codes, 5 of them on the Anthem Blue Cross and Blue Shield Virginia prior authorization list. Not a coverage decision; the payer's own document governs.
- Policy number
- MED.00140
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield Virginia prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross and Blue Shield Virginia policies |
|---|---|---|---|
| 38206 | On the list | Blood-Derived Hematopoietic Progenitor Cell Harvesting, Transplantation/Collection; Autologous | Policies naming 38206 |
| 38232 | On the list | Bone Marrow Harvesting For Transplantation; Autologous | Policies naming 38232 |
| 38241 | On the list | Hematopoietic progenitor cell (HPC); autologous transplantation | Policies naming 38241 |
| J3392 | On the list | Injection, exagamglogene autotemcel, per treatment | Policies naming J3392 |
| J3393 | On the list | Injection, betibeglogene autotemcel, per treatment | Policies naming J3393 |
All Anthem Blue Cross and Blue Shield Virginia policies · Anthem Blue Cross and Blue Shield Virginia prior authorization CPT list